EUSA Pharma

EUSA Pharma, Inc. operates as a specialty pharmaceutical company. It engages in the in-licensing, developing, and marketing of late-stage oncology, pain control, and critical care products. The company’s products include Caphosol for the treatment...

Founded in 2006
Employees: 76
Total money raised: $54.2M

OX4 4GA The Magdalen Centre
Oxford Science Park


Phone: 44 18 6578 4255

Updated on Sep 6, 2010
EUSA Pharma at CrunchBase
Bryan Morton President & CEO
Kevin Lokay CEO
Kevin J. Bratton CFO
David Cook CFO
Stephen A. Stamp Non-executive Director

April, 2012

EUSA Pharma was acquired by Jazz Pharmaceuticals
for $650M

Jazz Pharma Agrees To Buy EUSA Pharma For $650M

March, 2008

EUSA Pharma acquired EUSA Pharma for $22.6M

June, 2007

EUSA Pharma raised $9.1M in unattributed round from Hudson Bay Capital Management, OrbiMed Advisors, J.P. Morgan Securities Inc., RG Capital Management, First Eagle, Heights Capital Management, and Fort Mason Capital

November, 2006

EUSA Pharma raised $18.6M in unattributed round from Clarion Capital, Heights Capital Management, Fort Mason Capital, Hudson Bay Capital Management, Alexandra Investment Management, Highbridge Capital Management, Nite Capital Management, Acqua Wellington Asset Management, OrbiMed Advisors, Merlin Biomed, Oppenheim Pramerica Asset Management, Little Gem Life Sciences Capital Management, Banc of America Securities, Iroquois Capital, HBK Investments, and Rodman & Renshaw


EUSA Pharma was founded in 2006

December, 2005

EUSA Pharma raised $12.5M in unattributed round from Iroquois Capital, Highbridge Capital Management, Perceptive Advisors, Downsview Capital, and Bristol Capital Advisors

July, 2005

EUSA Pharma raised $14M in unattributed round from OrbiMed Advisors and ProQuest Investments